Modified optimal fractionation for poor prognosis malignant gliomas: An elusive search

References

• American Cancer Society. Cancer facts and figures. Atlanta, GA: American Cancer Society; 1996.
   Google Scholar
• Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 2000;50:7–33.
   PubMed Web of Science ®Google Scholar
• Kernohan JW, Sayre GP. Tumors of the central nervous system, American Registry of Patholo Gy, Washington, Armed Forces Institute of Patholo Gy, 1952.
   Google Scholar
• Shapiro WR. Therapy of adult malignant brain tumours: What have the clinical trials taught us? Semin Oncol 1986; 13:38–45.
   PubMed Web of Science ®Google Scholar
• Fine HA. The basis for current treatment recommendations for malignant gliomas. J Neuro Oncol 1994;20:111–21.
   PubMedGoogle Scholar
• Chamberlain MC, Kormanik PA. Practical guidelines for the treatment of malignant gliomas. West J Med 1998;168:114–20.
   PubMedGoogle Scholar
• Glioma Meta-analysis Trialists Group. Chemotherapy in adult high grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 2002;359:1011 —8.
   Google Scholar
• Medical Research Council Brain Tumour Working Party. Randomised trial of Procarbazine, Lomustine, and Vincris-tine in the adjuvant treatment of high grade astrocytomas: A Medical Research Council trial. J Chin Oncol 2001;19:509–18.
   PubMed Web of Science ®Google Scholar
• Curran Jr WJ, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncolo Gy Group malignant glioma trials. J Natl Can Inst 1993;85:9704–10.
   Google Scholar
• Gupta T, Sarin R. Poor prognosis high-grade gliomas: Evolving an evidence based standard of care. Lancet Oncol 2002;3:557–64.
   PubMed Web of Science ®Google Scholar
• Osoba D, Brada M, Yung WKA, et al. Health Related Quality of Life (HRQOL) in patients treated with temozo-lomide (TMZ) vs. Procarbazine (PCB) for recurrent GBM. J Chin Oncol 2000;18:1481–91.
   PubMed Web of Science ®Google Scholar
• Brandes AA, Vastola F, Basso U, et al. A prospective study on glioblastoma in the elderly. Cancer 2003;97:657–62.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, Van Den Bent MJ, et al. Concomitant and adjuvant temozolamide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Con-clusive results of a randomized phase III trial by EORTC Brain & RT Groups and NCIC Clinical Trials Group (Abstract 2, ASCO 2004). http://www.asco.org/adl, 1003, 12-002636-00 18-0026-00 19–001655, 00.asp
   Google Scholar
• Haas Kogan DA, Young G, Haas M, et al. p53 dependent G1 arrest and p53 independent apoptosis influence on the radiobiologic response of the GBM. hit J Radiat Oncol Biol Phys 1996;36:95–103.
   Google Scholar
• Douglas BG, Worth AJ. Superfractionation in gliblastoma multiforme. Results of a phase II study. Int J Radiat Oncol Biol Phys 1982;8:1787–94.
   PubMedGoogle Scholar
• Keim H, Polthoff PC, Schmidt K, et al. Survival and Quality of life after continuous accelerated radiotherapy of glioblas-toma. Radiother Oncol 1987;9:21–6.
   PubMed Web of Science ®Google Scholar
• Shenouda G, Souhami L, Freeman CR, et al. Accelerated fractionation for high grade cerebral astrocytomas. Prelimin-ary treatment results. Cancer 1991;67:2247–52.
   Google Scholar
• Brada M, Sharpe G, Rajan B, et al. Modifying radical radiotherapy in high grade gliomas: Shortening the treat-ment time through acceleration. hit J Radiat Oncol Biol Phys 1999;43:287–92.
   Google Scholar
• Fulton DS, Urtasun DS, Shin KH, et al. Misonidazole combined with hyperfractionation in the management of malignant gliomas. hit J Radiat Oncol Biol Phys 1984;10: 1709–12.
   PubMedGoogle Scholar
• Gonzalez GD, Menten J, Bosch DA, et al. Accelerated radiotherapy in glioblastoma multiforme: A dose searching prospective study. Radiother Oncol 1994;32(2):98–105.
   Google Scholar
• Fitzek MM, Thornton AF, Rabinov JD, et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 1999;91:251–60.
   PubMed Web of Science ®Google Scholar
• Buatti JM, Marcus RB, Mendenhall WM, et al. Accelerated hyperfractionated radiotherapy for malignant gliomas. hit J Radiat Oncol Biol Phys 1996;34:785–92.
   Google Scholar
• Bese NS, Omer U, Turkan S, et al. Continuous hyperfrac-tionated accelerated radiotherapy in the treatment of high grade astrocytomas. Radiother Oncol 1998;47:197–200.
   Google Scholar
• Lutterbach J, Weigel P, Guttenberger R. Accelerated hyper-fractionated radiotherapy in 149 patients with blioblastoma multiforme. Radiother Oncol 1999;53: 49–52.
   Google Scholar
• Neider C, Nestle U, Ketter R, et al. Hyperfractionated and accelerated hyperfractionated radiotherapy for glioblastoma multiforme. Radiat Oncol Invest 1999;7:36–41.
   Google Scholar
• Simpson WJ, Platt ME. Fractionation study in the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1976;1:639–44.
   PubMed Web of Science ®Google Scholar
• Payne DG, Simpson WJ, Keen C, et al. Malignant astro-cytoma —hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer 1982;50:2301–6.
   PubMed Web of Science ®Google Scholar
• Shin K, Muller P, Geegie P, et al. Superfractionation radiation therapy in the treatment of malignant astrocytoma. Cancer 1983;52:2040–3.
   PubMed Web of Science ®Google Scholar
• Shin KH, Urtasun RC, Fulton D, et al. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary re-port. Cancer 1985;56:758–60.
   Google Scholar
• Fulton DS, Urtasun RC, Scott-Brown I, et al. Increasing radiation dose intensity using hyperfractionation in patients with malignant gliomas. J Neuro-Oncol 1992;14:63–72.
   Google Scholar
• Ludgate C, Douglas B, Dixon P, et al. Superfractionated radiotherapy in Grade III, IV intracranial gliomas. hit J Radiat Oncol Biol Phys 1988;15:1091–5.
   PubMed Web of Science ®Google Scholar
• Horiot JC, vandenBogaert W, Ang KK, et al. EORTC trials using radiation therapy with multiple fractions per day 1978–1987 survey. In: Vaeth J, Meyer J, editors. Frontiers of radiation therapy oncolo Gy, vol. 22. Basel: Karger; 1988. p. 149–61.
   Google Scholar
• Prados MD, Wara WM, Sneed PK, et al. Phase III trial of accelerated hyperfractionation with or without difluromethy-lornithine (DFMO) vs. standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001;49:71 —7.
   Google Scholar
• Werner-Wasik M, Scott CB, Nelson DF, et al. Final report of a phase I/II trial of hyperfractionated and accelerates hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. RTOG study 83–02. Cancer 1996;77: 1535–43.
   Google Scholar
• Hinkelbein W, Bruggmoser G, Schmidt M, et al. Short term irradiation of glioblastomas with high dose single fraction (article in German). Strahlentherapie 1984;160:301–8.
   Google Scholar
• Mercial Vega VA, Wharom MD, Leibel S, et al. Treatment of supratentorial high grade glioma with split course high fractional dose post-operative radiotherapy. hit J Radiat Oncol Biol Phys 1989;16:1419–24.
   Google Scholar
• Tamura M, Nakamura M, Kuncimine H, et al. Large dose fraction radiotherapy in the treatment of glioblastoma. J Neuro-Oncol 1989;7:113–9.
   Google Scholar
• Bauman GS, Gasper LE, Fischer BJ, et al. A prospective study of short course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994;29:835 —9.
   Google Scholar
• Thomas R, James N, Guerrero D, et al. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade gliomas. Radiother Oncol 1994; 33:113–6.
   Google Scholar
• Slotman BJ, Kralendonk JH, van alphen HAM, et al. Hypofractionated radiation therapy in patients with glioblas-toma multiforme: results of treatment and impact of prog-nostic factors. Int J Radiat Oncol Biol Phys 1996;34:895–8.
   PubMed Web of Science ®Google Scholar
• Hoegler DB, Davey P. A prospective study of short course radiotherapy in the elderly patients with malignant glioma. J Neuro-Oncol 1997;33:201–4.
   PubMed Web of Science ®Google Scholar
• Ford JM, Stenning SP, Boote DJ, et al. A short fractionation radiotherapy for poor prognosis patients with high grade glioma. Clinical Oncol 1997;9:20–4.
   PubMedGoogle Scholar
• Lang O, Leibermeister E, Liesegang J, et al. Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall time. Strahlenther Onkol 1998; 174:629–32.
   Google Scholar
• Jeremic B, Shibamoto Y, Grujicic D, et al. Concurrent accelerated hyperfractionated radiation therapy and carbo-platin/etoposide in patients with malignant gliomas: Long term results of a phase II study. J Neuro-Oncol 2001; 51(2):133–41.
   Google Scholar
• Maarten CCMH, Schimmel EC, Bosch DA, et al. Hypo-fractionation in glioblastoma multiforme. Radiother Oncol 2000;54:143–8.
   Google Scholar
• McAleese JJ, Stenning SP, Ashley S, et al. Hypofractionated RT for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. Radiother Oncol 2003;67:177–82.
   PubMed Web of Science ®Google Scholar
• Glinski B. Postoperative hypofractionated radiotherapy vs. conventionally fractionated radiotherapy in malignant glio-mas: A preliminary report on a randomised trial. J Neuro-Oncol 1993;26:167–72.
   Google Scholar
• Philips C, Guiney M, Smith J, et al. A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrosytoma. Radiother Oncol 2003; 68:23–6.
   Google Scholar
• Roa W, Brashes PMA, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial. J Clin Oncol 2004;22:1583–8.
   PubMed Web of Science ®Google Scholar
• Floyd NS, Woo SY, The BS, et al. Hypofractionated intensity—modulated radiation therapy for primary glioblas-toma multiforme. Int J Radiat Oncol Biol Phys 2004; 58:721–6.
   PubMed Web of Science ®Google Scholar
• Sultanem K, Patrocinio H, Lambert C, et al. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: Preliminary results of a prospective trial. hit J Radiat Oncol Biol Phys 2004; 58:247–52.
   PubMed Web of Science ®Google Scholar
• Efficace F, Bottomley A. Assessing HRQOL: A neglected issue for high-grade glioma. Lancet Oncol 2003;4:11–2.
   PubMed Web of Science ®Google Scholar
• Efficace F, Bottomley A. Health-related quality of life assessment methodolo Gy and reported outcomes in rando-mized controlled trials of primary brain cancer patients. Eur J Cancer 2002;38:1824–31.
   PubMed Web of Science ®Google Scholar